Total Clarity Wealth Management, Inc. F Star Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$2.18 - $6.39 $4,360 - $12,780	2,000 New	2,000 $13,000
Q1 2022 Apr 29, 2022	SELL	$2.77 - $5.36 $9,695 - $18,760	-3,500 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$4.71 - $7.38 $14,130 - $22,140	3,000 Added 600.0%	3,500 $18,000
Q3 2021 Oct 21, 2021	BUY	$5.2 - $8.42 $2,600 - $4,210	500 New	500 $4,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.